185
Participants
Start Date
December 31, 1999
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Aldesleukin
Given IV
gp100 Antigen
Given SC
Montanide ISA 51 VG
Given SC
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Laboratory Biomarker Analysis
Correlative studies
Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
National Institutes of Health, Bethesda
Carolinas Medical Center, Charlotte
Emory University/Winship Cancer Institute, Atlanta
Lakeland Regional Cancer Center, Lakeland
University of Alabama at Birmingham, Birmingham
The James Graham Brown Cancer Center at University of Louisville, Louisville
Ohio State University Comprehensive Cancer Center, Columbus
The Christ Hospital, Cincinnati
IU Health Goshen Center for Cancer Care, Goshen
Aurora Saint Luke's Medical Center, Milwaukee
Advocate Lutheran General Hospital., Park Ridge
Northwestern University, Chicago
Rush University Medical Center, Chicago
M D Anderson Cancer Center, Houston
University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora
Mayo Clinic in Arizona, Scottsdale
Kaiser Permanente Medical Center, Riverside
Penn State Milton S Hershey Medical Center, Hershey
National Cancer Institute (NCI)
NIH